Hancock Whitney Corp Innoviva, Inc. Transaction History

Hancock Whitney Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$9.33 - $12.48 $95,809 - $128,157	-10,269 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$10.33 - $14.49 $1,425 - $1,999	-138 Reduced 1.33%	10,269 $107,000
Q2 2020 Jul 30, 2020	BUY	$11.49 - $15.26 $119,576 - $158,810	10,407 New	10,407 $145,000
Q1 2019 May 13, 2019	SELL	$13.69 - $20.06 $1.41 Million - $2.06 Million	-102,905 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$13.96 - $18.26 $56,216 - $73,533	-4,027 Reduced 3.77%	102,905 $1.8 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $1.46 Million - $1.68 Million	106,932 New	106,932 $1.63 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.